WMSA
ALT icon

Weiss Multi-Strategy Advisers’s Altimmune ALT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,600
Closed -$416K – 578
2022
Q3 		$416K Buy
+32,600
New +$481K 0.01% 562

Other funds holding ALT

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ALT Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Altimmune (ALT) in Q4 2022, closing a stake of 32,600 shares — an estimated $416K sold.

Weiss Multi-Strategy Advisers first reported a position in ALT in Q3 2022 and held it in 1 quarter. The position peaked at $416K in Q3 2022. 128 funds tracked by Wall St. Rank hold ALT as of Q4 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Altimmune position as of Q4 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 32,600 Altimmune shares in Q4 2022, an estimated $416K.
  • Weiss Multi-Strategy Advisers first reported a position in Altimmune in Q3 2022 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Altimmune position peaked at $416K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held Altimmune as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.